Steve Smith
Steve Smith is Head of Rare Diseases and Cell & Gene Therapy at Next Phase Recruitment – a specialist consultancy with a pro-active focus on tackling the talent gaps for cell & gene therapy businesses globally. Steve has 11 years’ experience in life sciences recruitment, the most recent of which has been helping start-up businesses to secure accomplished leaders with backgrounds in the rare diseases and cell & gene therapy space. He forms part of the wider Next Phase Cell & Gene Therapy team that cover all functions of recruitment solutions, including Drug Discovery, R&D, Manufacturing, Clinical Operations and Commercial …
Steve Smith is Head of Rare Diseases and Cell & Gene Therapy at Next Phase Recruitment – a specialist consultancy with a pro-active focus on tackling the talent gaps for cell & gene therapy businesses globally.
Steve has 11 years’ experience in life sciences recruitment, the most recent of which has been helping start-up businesses to secure accomplished leaders with backgrounds in the rare diseases and cell & gene therapy space.
He forms part of the wider Next Phase Cell & Gene Therapy team that cover all functions of recruitment solutions, including Drug Discovery, R&D, Manufacturing, Clinical Operations and Commercial Products.
See more
Steve has 11 years’ experience in life sciences recruitment, the most recent of which has been helping start-up businesses to secure accomplished leaders with backgrounds in the rare diseases and cell & gene therapy space.
He forms part of the wider Next Phase Cell & Gene Therapy team that cover all functions of recruitment solutions, including Drug Discovery, R&D, Manufacturing, Clinical Operations and Commercial Products.
Articles: Steve Smith
Tackling the Talent Gap in Cell & Gene Therapy
Opinion / Rare diseases and cell and gene therapy executive recruitment specialist Steve Smith outlines six key strategies for attracting and retaining talent in these rapidly emerging fields. In a young industry experiencing rapid growth, talent demand far outweighs supply Cell & Gene Therapy; “It’s no longer something people read about in the paper and think…
Latest Report
